A Bone Health Exposé for World Osteoporosis Day
By Cary Davies
1 October 2024
In celebration of World Osteoporosis Day, Next Biosciences brings you an updated perspective on the importance of early intervention for the protection of bone health.
Will a healthy lifestyle prevent Alzheimer’s disease?
By Cary Davies
1 October 2024
While family history strongly influences the development of early onset Alzheimer’s disease, late onset Alzheimer’s disease appears to be more responsive to lifestyle intervention.
Winning combination: Is athletic potential governed by a genetic code?
By Cary Davies
26 August 2024
There is much deliberation about whether sporting skill stems from the inheritance of physiological talent or psychological discipline. The role of inherited habits has ample standing in the nature versus nurture debate across most domains, but how much weight the genetic code carries in the sporting arena poses an extremely interesting question.
The full picture of you: How genetic testing can provide a well-rounded view
By Cary Davies
15 August 2024
The more we know about our bodies, the better equipped we are to manage our health and well-being. Although healthcare is largely a reactive practice, the importance of proactive care is more apparent than ever.
Next Biosciences holds a compass for all women to navigate life and health.
By Cary Davies
8 August 2024
Metabolic health, hormone balance, fertility, and the transition into motherhood can all present unexpected obstacles along the way.
Child-proofing paediatric prescriptions: Insights to alleviate parental anxiety
By Cary Davies
16 July 2024
Putting a child on chronic medication presents a logical dilemma to many parents when weighing up the compromise between the proposed drug benefits and the potential side-effects.
Is diabetes an inherited condition or a disease of lifestyle?
By Cary Davies
4 July 2024
To understand the role that lifestyle factors can play in the prevention and management of diabetes, it is first necessary to clarify the stark differences between type 1 and type 2 variations of the disease.
Pharmaco-economics: The cost-effectiveness of using Pharmacogenomics (PGx) to guide prescription choices.
By Caela De Beer
27 June 2024
When it comes to genetic testing, a general concern expressed by healthcare providers is the initial financial outlay of the patients since most genetic tests are not currently covered by medical aids. However, it is important to consider the benefits and cost effectiveness downstream.
Clinical utility and evidence-based SNP selection for nutrigenetic testing
By Caela De Beer
15 June 2024
Helping your patient achieve their health goals with the best possible outcomes is a journey that a practitioner walks alongside and guides their patient through. It is part of your responsibility that the guidance you give provides the patient with actionable tools that they can use to achieve these goals.
Next Biosciences
Ariane Avenue
International Business Gateway
Cnr. New Road and 6th Road
Midrand, South Africa
Office Hours
Monday - Thursday: 08h00 - 17h00
Friday: 08h00 - 16h00